Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCaution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia.AuthorsGambacorti‐Passerini, Carlo; Nicolini, Franck Emmanuel; Larson, Richard A.; Aroldi, Andrea; Fontana, Diletta; Piazza, Rocco; le Coutre, Philipp; Antolini, Laura; Assouline, SaritPublicationAmerican Journal of Hematology, 2022, Vol 97, Issue 8, pE296ISSN0361-8609Publication typeArticleDOI10.1002/ajh.26618